Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
A policy on generic substitutions, which is aimed at reducing the cost-effectiveness of pharmacotherapy, was proposed by the WHO at the end of the 20th century; however, but the debate about their economic benefits has continued until now. There have been the most active discussions of whether an...
Main Authors: | E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2018-07-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/913 |
Similar Items
-
Generic Substitutions for Antiepileptic Drugs
by: J Gordon Millichap
Published: (1990-11-01) -
Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018-02-01) -
Representative sample survey on factors determining the Czech physicians’ awareness of generic drugs and substitution
by: J. Maly, et al.
Published: (2019-10-01) -
Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01) -
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force
by: Jenna Niyongere, et al.
Published: (2022-06-01)